|
1
|
Gondivkar SM, Gadbail AR, Chole R and
Parikh RV: Adenoid cystic carcinoma: A rare clinical entity and
literature review. Oral Oncol. 47:231–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li LJ, Li Y, Wen YM, Liu H and Zhao HW:
Clinical analysis of salivary gland tumor cases in West China in
past 50 years. Oral Oncol. 44:187–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Umeda M, Nishimatsu N, Masago H, Ishida Y,
Yokoo S, Fujioka M, Shibuya Y and Komori T: Tumor-doubling time and
onset of pulmonary metastasis from adenoid cystic carcinoma of the
salivary gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
88:473–478. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rampling R, Cruickshank G, Lewis AD,
Fitzsimmons SA and Workman P: Direct measurement of pO2
distribution and bioreductive enzymes in human malignant brain
tumors. Int J Radiat Oncol Biol Phys. 29:427–431. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kayama T, Yoshimoto T, Fujimoto S and
Sakurai Y: Intratumoral oxygen pressure in malignant brain tumor. J
Neurosurg. 74:55–59. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
7
|
Semenza GL: HIF-1: Mediator of
physiological and pathophysiological responses to hypoxia. J Appl
Physiol. 88:1474–1480. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Covello KL and Simon MC: HIFs, hypoxia,
and vascular development. Curr Top Dev Biol. 62:37–54. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stoeltzing O, McCarty MF, Wey JS, Fan F,
Liu W, Belcheva A, Bucana CD, Semenza GL and Ellis LM: Role of
hypoxia-inducible factor 1alpha in gastric cancer cell growth,
angiogenesis, and vessel maturation. J Natl Cancer Inst.
96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Samanta D, Gilkes DM, Chaturvedi P, Xiang
L and Semenza GL: Hypoxia-inducible factors are required for
chemotherapy resistance of breast cancer stem cells. Proc Natl Acad
Sci USA. 111:E5429–E5438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harada H: How can we overcome tumor
hypoxia in radiation therapy? J Radiat Res. 52:545–556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Semenza GL: Development of novel
therapeutic strategies that target HIF-1. Expert Opin Ther Targets.
10:267–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee FS and Percy MJ: The HIF pathway and
erythrocytosis. Annu Rev Pathol. 6:165–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang GL and Semenza GL: Purification and
characterization of hypoxia-inducible factor 1. J Biol Chem.
270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pugh CW, O'Rourke JF, Nagao M, Gleadle JM
and Ratcliffe PJ: Activation of hypoxia-inducible factor-1;
definition of regulatory domains within the alpha subunit. J Biol
Chem. 272:11205–11214. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meijer TW, Kaanders JH, Span PN and
Bussink J: Targeting hypoxia, HIF-1, and tumor glucose metabolism
to improve radiotherapy efficacy. Clin Cancer Res. 18:5585–5594.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Łuczak MW, Roszak A, Pawlik P, Kędzia H,
Lianeri M and Jagodziński PP: Increased expression of HIF-1A and
its implication in the hypoxia pathway in primary advanced uterine
cervical carcinoma. Oncol Rep. 26:1259–1264. 2011.PubMed/NCBI
|
|
19
|
Sun X, Vale M, Jiang X, Gupta R and
Krissansen GW: Antisense HIF-1alpha prevents acquired tumor
resistance to angiostatin gene therapy. Cancer Gene Ther.
17:532–540. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen W, Xi H, Wei B and Chen L: The
prognostic role of matrix metalloproteinase 2 in gastric cancer: A
systematic review with meta-analysis. J Cancer Res Clin Oncol.
140:1003–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deryugina EI and Quigley JP: Tumor
angiogenesis: MMP-mediated induction of intravasation- and
metastasis-sustaining neovasculature. Matrix Biol 44–46. 1–112.
2015.
|
|
23
|
Chekhonin VP, Shein SA, Korchagina AA and
Gurina OI: VEGF in tumor progression and targeted therapy. Curr
Cancer Drug Targets. 13:423–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong J, Yang Q, Li J and Zhou S: Effects
of MDM2 inhibitors on vascular endothelial growth factor-mediated
tumor angiogenesis in human breast cancer. Angiogenesis. 17:37–50.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan F, Wang C, Li T, Cai W and Sun J: Role
of miR-21 in the growth and metastasis of human salivary adenoid
cystic carcinoma. Mol Med Rep. 17:4237–4244. 2018.PubMed/NCBI
|
|
26
|
Zimna A and Kurpisz M: Hypoxia-inducible
factor-1 in physiological and pathophysiological angiogenesis:
Applications and therapies. Biomed Res Int. 2015:5494122015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song T, Zhang X, Wang C, Wu Y, Cai W, Gao
J and Hong B: MiR-138 suppresses expression of hypoxia-inducible
factor 1α (HIF-1 α) in clear cell renal cell carcinoma 786-O cells.
Asian Pac J Cancer Prev. 12:1307–1311. 2011.PubMed/NCBI
|
|
28
|
Roslavtceva VV, Salmina AB, Prokopenko SV,
Pozhilenkova EA, Kobanenko IV and Rezvitskaya GG: The role of
vascular endothelial growth factor in the regulation of development
and functioning of the brain: New target molecules for
pharmacotherapy. Biomed Khim. 62:124–133. 2016.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu B, Miao ZH, Jiang Y, Li MH, Yang N, Li
T and Ding J: c-Jun protects hypoxia-inducible factor-1alpha from
degradation via its oxygen-dependent degradation domain in a
nontranscriptional manner. Cancer Res. 69:7704–7712. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi L, Zhu F, Li SH, Si LB, Hu LK and Tian
H: Retinoblastoma binding protein 2 (RBP2) promotes
HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via
the Akt pathway. PLoS One. 9:e1060322014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ravi R, Mookerjee B, Bhujwalla ZM, Sutter
CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A:
Regulation of tumor angiogenesis by p53-induced degradation of
hypoxia-inducible factor 1alpha. Genes Dev. 14:34–44.
2000.PubMed/NCBI
|
|
32
|
Tang N, Wang L, Esko J, Giordano FJ, Huang
Y, Gerber HP, Ferrara N and Johnson RS: Loss of HIF-1alpha in
endothelial cells disrupts a hypoxia-driven VEGF autocrine loop
necessary for tumorigenesis. Cancer Cell. 6:485–495. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YA, Choi HM, Lee SH, Hong SJ, Yang HI,
Yoo MC and Kim KS: Hypoxia differentially affects IL-1β-stimulated
MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an
HIF-1α-dependent manner. Rheumatology. 51:443–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang YL, Liu X, Gao SY, Feng H, Jiang YP,
Wang SS, Yang J, Jiang J, Ma XR, Tang YJ, et al: WIP1 stimulates
migration and invasion of salivary adenoid cystic carcinoma by
inducing MMP-9 and VEGF-C. Oncotarget. 6:9031–9044. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wucherpfennig AL, Li YP, Stetler-Stevenson
WG, Rosenberg AE and Stashenko P: Expression of 92 kD type IV
collagenase/gelatinase B in human osteoclasts. J Bone Miner Res.
9:549–556. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nagase H: Matrix metalloproteinases. A
mini-review. Contrib Nephrol. 107:85–93. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu CT, Bi KW, Huang CC, Wu HT, Ho HY, S
Pang JH and Huang ST: Davallia bilabiata exhibits anti-angiogenic
effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF
ligand/receptors expression in vascular endothelial cells. J
Ethnopharmacol. 196:213–224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang F, Chang M, Shi Y, Jiang L, Zhao J,
Hai L, Sharen G and Du H: Down-regulation of hypoxia-inducible
factor-1 suppresses malignant biological behavior of
triple-negative breast cancer cells. Int J Clin Exp Med.
7:3933–3940. 2014.PubMed/NCBI
|
